Top in glaucoma 2023: Association of medications with acute angle-closure glaucoma
Click Here to Manage Email Alerts
The top Healio glaucoma-related items this year covered the association between acute angle-closure glaucoma and certain medications, as well as a discussion about a needed paradigm shift in the approach to glaucoma treatment.
Check out the most popular glaucoma items from 2023 below.
Image: Adobe Stock
Study investigates association of drugs with acute angle-closure glaucoma
A case-crossover study conducted on a large health care database in South Korea shed light on the association between acute angle-closure glaucoma and a number of prescription and nonprescription medications. Read more.
BLOG: Glaucoma needs a new standard of care
Generations of ophthalmologists have treated primary open-angle glaucoma largely the same way, instituting and escalating the dosages of drops. Read more.
VIDEO: Glaucoma surgeons face reimbursement issues with MIGS
In this Healio Video Perspective from OSN New York, Nathan M. Radcliffe, MD, discusses reimbursement issues for minimally invasive glaucoma surgery. Watch here.
VIDEO: Bimatoprost drug delivery platform offers encouraging 6-month results
In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Malik Y. Kahook, MD, discusses study data investigating the Spyglass drug delivery platform, which offers sustained delivery of bimatoprost. Watch here.
Low diastolic BP may be associated with ganglion cell complex damage in glaucoma
The combination of low diastolic blood pressure and high IOP in patients with moderate to advanced glaucoma was associated with faster ganglion cell complex thinning rates. Read more.
Collapse
Healio Coverage
Click Here to Manage Email Alerts